Altered expression of TIM‐3, LAG‐3, IDO, PD‐L1, and CTLA‐4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients-Reference-Cited by-同舟云学术

Altered expression of TIM‐3, LAG‐3, IDO, PD‐L1, and CTLA‐4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients

Published:2019-06-09 Issue:8 Volume:48 Page:669-676
ISSN:0904-2512
Container-title:Journal of Oral Pathology & Medicine
language:en
Short-container-title:J Oral Pathol Med

Author:

Wang Hong¹²³,Mao Lu¹²³,Zhang Tian²³,Zhang Liming²³,Wu Yuteng²³,Guo Wei²³,Hu Jingzhou²³,Ju Houyu²³,Ren Guoxin¹²³^ORCID

Affiliation:

1. College of Stomatology Weifang Medical University Weifang China

2. Department of Oral Maxillofacial‐Head and Neck Oncology, Shanghai Ninth People’s Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

3. Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology National Clinical Research Center of Stomatology Shanghai China

Publisher

Wiley

Subject

Periodontics,Cancer Research,Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jop.12883

Reference29 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

3. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)

4. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma

5. The prognostic value of immune checkpoints in oral squamous cell carcinoma

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the current potential of immunotherapeutic-based treatment approaches for the management of oral cancer: An updated review;Oral Oncology Reports;2024-06

2. PD-1 and LAG-3 positive T cells are related with the prognosis of patients with chronic kidney disease;Experimental Cell Research;2024-05

3. Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review;Biology;2024-02-06

4. Application of Bioinformatics in Predicting the Efficacy of Digestive Tumour Immunotherapy Target TIM-3 and its Inhibitors;Journal of Cancer;2024

5. Le cancer de la cavité orale : une entité spécifique ?;médecine/sciences;2024-01